Temozolomide, sold under the brand name Temodar among others, is an anticancer medication used to treat brain tumors such as glioblastoma and anaplastic astrocytoma. It is taken by mouth or via intravenous infusion. From Wikipedia
Researchers at Virginia Tech discover PI3K-beta as a key target to enhance the efficacy of temozolomide in treating glioblastoma.